Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)
Date : 01/12/2015 @ 8:38AM
Source : Edgar (US Regulatory)
Stock : Tapimmune, Inc. (QB) (TPIV)
Quote : 0.312 0.0 (0.00%) @ 7:54AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)
Print
Alert
Filed Pursuant to Rule 424(b)(5)
Registration No. 333-196115
PROSPECTUS SUPPLEMENT
(To Prospectus dated July 21, 2014)
7,320,000 UNITS
Each Unit Consisting of
One Share of Common Stock
One Series A Warrant to Purchase One Share of Common Stock
One Series B Warrant to Purchase One Share of Common Stock
One Series C Warrant to Purchase One Share of Common Stock
One Series D Warrant to Purchase One Share of Common Stock
One Series E Warrant to Purchase One Share of Common Stock
Pursuant to this prospectus supplement and the accompanying prospectus, we are offering 7,320,000 units, with each unit consisting of (i) one share of common stock, par value $0.001, (ii) one Series A warrant to purchase one share of common stock, (ii) one Series B warrant to purchase one share of common stock, (iii) one Series C warrant to purchase one share of common stock, (iv) one Series D warrant to purchase one share of common stock, and (v) one Series E warrant to purchase one share of common stock, at a public offering price of $0.20 per unit. Each Series A warrant will have an initial exercise price of $1.50 per share, will be immediately exercisable and will expire on the five year anniversary of the date of issuance. Each Series B warrant will have an initial exercise price of $0.40 per share, will be immediately exercisable, may be redeemed by us in the event that the closing price of our stock is above $0.70 for 20 consecutive trading days (subject to certain conditions including minimum trading volume requirements), and will expire on the six month anniversary of the date of issuance. Each Series C warrant will have an initial exercise price of $1.00 per share, will be immediately exercisable, may be redeemed by us in the event that the closing price of our stock is above $1.50 for 20 consecutive trading days (subject to certain conditions including minimum trading volume requirements), and will expire on the five year anniversary of the date of issuance. Each Series D warrant will be exercisable only if and to the extent that the Series B warrants are exercised, will have an initial exercise price of $0.75 per share, and will expire on the five year anniversary of the date that the Series B warrant is initially exercised. Each Series E warrant will be exercisable only if and to the extent that the Series C warrants are exercised, will have an initial exercise price of $1.25 per share, and will expire on the five year anniversary of the date that the Series C warrant is initially exercised. Units will not be issued or certificated. The shares of common stock and the warrants will be issued separately but can only be purchased together as units in this offering. This prospectus supplement also relates to the offering of the shares of common stock issuable upon the exercise of the warrants issued in this offering. The units can only be purchased in this offering.
Our common stock is currently quoted on the OTCBB under the symbol “TPIV”. On January 7, 2015, the last reported sales price per share of our common stock on the OTCBB was $0.32.
Investing in our securities involves a high degree of risk. You should review carefully the risks and uncertainties described in the section titled “Risk Factors” on page S-5 of this prospectus supplement, page 5 of the accompanying prospectus and under similar headings in the other documents that are incorporated by reference into this prospectus.
Harleyman!
